Regarding a Randomized Controlled Trial on Allopurinol for Secondary Prevention of Cirrhosis-Related Complications

Am J Med. 2024 Dec;137(12):e240-e241. doi: 10.1016/j.amjmed.2024.04.009.

Author

Mackenzie Balzan¹

Affiliation

¹ Nanaimo Regional General Hospital, BC, Canada; University of British Columbia, Vancouver, Canada. Electronic address: mackenzie.balzan@islandhealth.ca.

PMID: 39580207
DOI: 10.1016/j.amjmed.2024.04.009

No abstract available

Publication types

Letter